Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Dec, 2019 | Pages:
165 | Publisher: 9Dimen Research
Industry: Pharmaceutical | Report Format: Electronic (PDF)
The global oral anti-diabetic drug market share is expected to witness a surge during the forecast period, according to a report available on Radiant Insights. Surge in cases of type 2 diabetes and increase in scope of pathophysiology is likely to enhance the market development throughout the forecast period. High prevalence of type 2 diabetes is evident across the globe and it is gaining a huge impetus in the geriatric population. At present, sulfonylurea’s is the most widely used pharmacologic agents in the treatment of type 2 diabetes. The response rate is high in the initial stages, however, it seems to attain a decline as it reaches peak. As biguanide are used as adjuvants to sulfonylureas, gastrointestinal intolerance limits their use in several patients. Therefore, a large number of patients with type 2 diabetes exhibit weak gut performance and loosened metabolic control. Following the contemporary diagnosis and availability of pharmacological agents for regulating blood flow and control has induced a high-end research for antidiabetic agents with different result and endpoints. The market for oral anti-diabetic drug market is significantly driven by enormous rise in the prevalence of diabetic patients worldwide. Additionally, the market is also influenced due to the significant increase in economic costs and rise in the number of patients with diabetic conditions. Inhibitors have less side effects on consumption and therefore, it is gaining a huge traction in the forthcoming years. Anti-diabetic drugs can be used as combinational therapies for regulating oral and diabetic conditions and hence, it is receiving a wide attention in the drug category. Based on the product segmentation, oral anti-diabetic drug market includes Gliclazide, Glimepiride, and Glyburide. Glicalizide gained a huge momentum in the past few years due to the rise in demand and proven effectiveness in patients. Based on end-user, oral anti-diabetic drug market includes hospital, and research institutions. Hospitals accounted for the large share attributing to adoption of a well-suited healthcare infrastructure. Presence of a competent workforce and economic costs is likely to propel the growth of the segment. Based on the regional segmentation, oral anti-diabetic drug market comprises North Ameria, South America, Europe, Asia Pacific, Middle-East and Africa. Asia Pacific is the leading market attributing to increase in prevalence of diabetes and rise in launch of novel drugs having high efficiency North America holds a leading market share attributing to increase in reimbursement policies and the presence of a relevant market infrastructure. Presence of diabetic population triggers the market development for oral treatment and diagnosis. Some of the key players in the oral anti-diabetic drug market are Pfizer, Takeda, Jannsen Pharmaceuticals, Asetellas, Merck and Co, Boehringer Ingelheim, AstraZeneca, Bristol Myers Squib, Novartis, Sanofi, Abbott, and Biocon. The key players are adopting mergers and acquisition, collaboration, strategic partnerships, and other growth strategies for expansion. Anti-diabetic drug refers to the medications consumed orally that are prescribed to treat diabetes mellitus (type 2). It treats diabetes (type 2) by lowering down the blood sugar level. These are also known as oral hypoglycemic agentsororal antihyperglycemic agents. Oral anti-diabetic drugs are often prescribed as monotherapy but in severe cases, can be given in combination with insulin. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Oral Anti-Diabetic Drug Report by Material, Application, and Geography - Global Forecast to 2023 is a professional and comprehensive research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China). In this report, the global Oral Anti-Diabetic Drug market is valued at USD XX million in 2020 and is projected to reach USD XX million by the end of 2024, growing at a CAGR of XX% during the period 2020 to 2024. The report firstly introduced the Oral Anti-Diabetic Drug basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis. The major players profiled in this report include: • Takeda • Pfizer • Eli Lilly • Janssen Pharmaceuticals • Astellas • Boehringer Ingelheim • Merck And Co. • AstraZeneca • Bristol Myers Squibb • Novartis • Sanofi • Abbott • Biocon The end users/applications and product categories analysis: On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split into- • Glimepiride • Gliclazide • Glyburide On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Oral Anti-Diabetic Drug for each application, including- • Hospital • Research Institual
Table of Contents Part I Oral Anti-Diabetic Drug Industry Overview Chapter One Oral Anti-Diabetic Drug Industry Overview 1.1 Oral Anti-Diabetic Drug Definition 1.2 Oral Anti-Diabetic Drug Classification Analysis 1.2.1 Oral Anti-Diabetic Drug Main Classification Analysis 1.2.2 Oral Anti-Diabetic Drug Main Classification Share Analysis 1.3 Oral Anti-Diabetic Drug Application Analysis 1.3.1 Oral Anti-Diabetic Drug Main Application Analysis 1.3.2 Oral Anti-Diabetic Drug Main Application Share Analysis 1.4 Oral Anti-Diabetic Drug Industry Chain Structure Analysis 1.5 Oral Anti-Diabetic Drug Industry Development Overview 1.5.1 Oral Anti-Diabetic Drug Product History Development Overview 1.5.1 Oral Anti-Diabetic Drug Product Market Development Overview 1.6 Oral Anti-Diabetic Drug Global Market Comparison Analysis 1.6.1 Oral Anti-Diabetic Drug Global Import Market Analysis 1.6.2 Oral Anti-Diabetic Drug Global Export Market Analysis 1.6.3 Oral Anti-Diabetic Drug Global Main Region Market Analysis 1.6.4 Oral Anti-Diabetic Drug Global Market Comparison Analysis 1.6.5 Oral Anti-Diabetic Drug Global Market Development Trend Analysis Chapter Two Oral Anti-Diabetic Drug Up and Down Stream Industry Analysis 2.1 Upstream Raw Materials Analysis 2.1.1 Proportion of Manufacturing Cost 2.1.2 Manufacturing Cost Structure of Oral Anti-Diabetic Drug Analysis 2.2 Down Stream Market Analysis 2.2.1 Down Stream Market Analysis 2.2.2 Down Stream Demand Analysis 2.2.3 Down Stream Market Trend Analysis Part II Asia Oral Anti-Diabetic Drug Industry (The Report Company Including the Below Listed But Not All) Chapter Three Asia Oral Anti-Diabetic Drug Market Analysis 3.1 Asia Oral Anti-Diabetic Drug Product Development History 3.2 Asia Oral Anti-Diabetic Drug Competitive Landscape Analysis 3.3 Asia Oral Anti-Diabetic Drug Market Development Trend Chapter Four 2015-2020 Asia Oral Anti-Diabetic Drug Productions Supply Sales Demand Market Status and Forecast 4.1 2015-2020 Oral Anti-Diabetic Drug Production Overview 4.2 2015-2020 Oral Anti-Diabetic Drug Production Market Share Analysis 4.3 2015-2020 Oral Anti-Diabetic Drug Demand Overview 4.4 2015-2020 Oral Anti-Diabetic Drug Supply Demand and Shortage 4.5 2015-2020 Oral Anti-Diabetic Drug Import Export Consumption 4.6 2015-2020 Oral Anti-Diabetic Drug Cost Price Production Value Gross Margin Chapter Five Asia Oral Anti-Diabetic Drug Key Manufacturers Analysis 5.1 Company A 5.1.1 Company Profile 5.1.2 Product Picture and Specification 5.1.3 Product Application Analysis 5.1.4 Capacity Production Price Cost Production Value 5.1.5 Contact Information 5.2 Company B 5.2.1 Company Profile 5.2.2 Product Picture and Specification 5.2.3 Product Application Analysis 5.2.4 Capacity Production Price Cost Production Value 5.2.5 Contact Information 5.3 Company C 5.3.1 Company Profile 5.3.2 Product Picture and Specification 5.3.3 Product Application Analysis 5.3.4 Capacity Production Price Cost Production Value 5.3.5 Contact Information 5.4 Company D 5.4.1 Company Profile 5.4.2 Product Picture and Specification 5.4.3 Product Application Analysis 5.4.4 Capacity Production Price Cost Production Value 5.4.5 Contact Information Chapter Six Asia Oral Anti-Diabetic Drug Industry Development Trend 6.1 2020-2024 Oral Anti-Diabetic Drug Production Overview 6.2 2020-2024 Oral Anti-Diabetic Drug Production Market Share Analysis 6.3 2020-2024 Oral Anti-Diabetic Drug Demand Overview 6.4 2020-2024 Oral Anti-Diabetic Drug Supply Demand and Shortage 6.5 2020-2024 Oral Anti-Diabetic Drug Import Export Consumption 6.6 2020-2024 Oral Anti-Diabetic Drug Cost Price Production Value Gross Margin Part III North American Oral Anti-Diabetic Drug Industry (The Report Company Including the Below Listed But Not All) Chapter Seven North American Oral Anti-Diabetic Drug Market Analysis 7.1 North American Oral Anti-Diabetic Drug Product Development History 7.2 North American Oral Anti-Diabetic Drug Competitive Landscape Analysis 7.3 North American Oral Anti-Diabetic Drug Market Development Trend Chapter Eight 2015-2020 North American Oral Anti-Diabetic Drug Productions Supply Sales Demand Market Status and Forecast 8.1 2015-2020 Oral Anti-Diabetic Drug Production Overview 8.2 2015-2020 Oral Anti-Diabetic Drug Production Market Share Analysis 8.3 2015-2020 Oral Anti-Diabetic Drug Demand Overview 8.4 2015-2020 Oral Anti-Diabetic Drug Supply Demand and Shortage 8.5 2015-2020 Oral Anti-Diabetic Drug Import Export Consumption 8.6 2015-2020 Oral Anti-Diabetic Drug Cost Price Production Value Gross Margin Chapter Nine North American Oral Anti-Diabetic Drug Key Manufacturers Analysis 9.1 Company A 9.1.1 Company Profile 9.1.2 Product Picture and Specification 9.1.3 Product Application Analysis 9.1.4 Capacity Production Price Cost Production Value 9.1.5 Contact Information 9.2 Company B 9.2.1 Company Profile 9.2.2 Product Picture and Specification 9.2.3 Product Application Analysis 9.2.4 Capacity Production Price Cost Production Value 9.2.5 Contact Information Chapter Ten North American Oral Anti-Diabetic Drug Industry Development Trend 10.1 2020-2024 Oral Anti-Diabetic Drug Production Overview 10.2 2020-2024 Oral Anti-Diabetic Drug Production Market Share Analysis 10.3 2020-2024 Oral Anti-Diabetic Drug Demand Overview 10.4 2020-2024 Oral Anti-Diabetic Drug Supply Demand and Shortage 10.5 2020-2024 Oral Anti-Diabetic Drug Import Export Consumption 10.6 2020-2024 Oral Anti-Diabetic Drug Cost Price Production Value Gross Margin Part IV Europe Oral Anti-Diabetic Drug Industry Analysis (The Report Company Including the Below Listed But Not All) Chapter Eleven Europe Oral Anti-Diabetic Drug Market Analysis 11.1 Europe Oral Anti-Diabetic Drug Product Development History 11.2 Europe Oral Anti-Diabetic Drug Competitive Landscape Analysis 11.3 Europe Oral Anti-Diabetic Drug Market Development Trend Chapter Twelve 2015-2020 Europe Oral Anti-Diabetic Drug Productions Supply Sales Demand Market Status and Forecast 12.1 2015-2020 Oral Anti-Diabetic Drug Production Overview 12.2 2015-2020 Oral Anti-Diabetic Drug Production Market Share Analysis 12.3 2015-2020 Oral Anti-Diabetic Drug Demand Overview 12.4 2015-2020 Oral Anti-Diabetic Drug Supply Demand and Shortage 12.5 2015-2020 Oral Anti-Diabetic Drug Import Export Consumption 12.6 2015-2020 Oral Anti-Diabetic Drug Cost Price Production Value Gross Margin Chapter Thirteen Europe Oral Anti-Diabetic Drug Key Manufacturers Analysis 13.1 Company A 13.1.1 Company Profile 13.1.2 Product Picture and Specification 13.1.3 Product Application Analysis 13.1.4 Capacity Production Price Cost Production Value 13.1.5 Contact Information 13.2 Company B 13.2.1 Company Profile 13.2.2 Product Picture and Specification 13.2.3 Product Application Analysis 13.2.4 Capacity Production Price Cost Production Value 13.2.5 Contact Information Chapter Fourteen Europe Oral Anti-Diabetic Drug Industry Development Trend 14.1 2020-2024 Oral Anti-Diabetic Drug Production Overview 14.2 2020-2024 Oral Anti-Diabetic Drug Production Market Share Analysis 14.3 2020-2024 Oral Anti-Diabetic Drug Demand Overview 14.4 2020-2024 Oral Anti-Diabetic Drug Supply Demand and Shortage 14.5 2020-2024 Oral Anti-Diabetic Drug Import Export Consumption 14.6 2020-2024 Oral Anti-Diabetic Drug Cost Price Production Value Gross Margin Part V Oral Anti-Diabetic Drug Marketing Channels and Investment Feasibility Chapter Fifteen Oral Anti-Diabetic Drug Marketing Channels Development Proposals Analysis 15.1 Oral Anti-Diabetic Drug Marketing Channels Status 15.2 Oral Anti-Diabetic Drug Marketing Channels Characteristic 15.3 Oral Anti-Diabetic Drug Marketing Channels Development Trend 15.2 New Firms Enter Market Strategy 15.3 New Project Investment Proposals Chapter Sixteen Development Environmental Analysis 16.1 China Macroeconomic Environment Analysis 16.2 European Economic Environmental Analysis 16.3 United States Economic Environmental Analysis 16.4 Japan Economic Environmental Analysis 16.5 Global Economic Environmental Analysis Chapter Seventeen Oral Anti-Diabetic Drug New Project Investment Feasibility Analysis 17.1 Oral Anti-Diabetic Drug Market Analysis 17.2 Oral Anti-Diabetic Drug Project SWOT Analysis 17.3 Oral Anti-Diabetic Drug New Project Investment Feasibility Analysis Part VI Global Oral Anti-Diabetic Drug Industry Conclusions Chapter Eighteen 2015-2020 Global Oral Anti-Diabetic Drug Productions Supply Sales Demand Market Status and Forecast 18.1 2015-2020 Oral Anti-Diabetic Drug Production Overview 18.2 2015-2020 Oral Anti-Diabetic Drug Production Market Share Analysis 18.3 2015-2020 Oral Anti-Diabetic Drug Demand Overview 18.4 2015-2020 Oral Anti-Diabetic Drug Supply Demand and Shortage 18.5 2015-2020 Oral Anti-Diabetic Drug Import Export Consumption 18.6 2015-2020 Oral Anti-Diabetic Drug Cost Price Production Value Gross Margin Chapter Nineteen Global Oral Anti-Diabetic Drug Industry Development Trend 19.1 2020-2024 Oral Anti-Diabetic Drug Production Overview 19.2 2020-2024 Oral Anti-Diabetic Drug Production Market Share Analysis 19.3 2020-2024 Oral Anti-Diabetic Drug Demand Overview 19.4 2020-2024 Oral Anti-Diabetic Drug Supply Demand and Shortage 19.5 2020-2024 Oral Anti-Diabetic Drug Import Export Consumption 19.6 2020-2024 Oral Anti-Diabetic Drug Cost Price Production Value Gross Margin Chapter Twenty Global Oral Anti-Diabetic Drug Industry Research Conclusions
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
